Stem Cells Blog

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

Join our panel of experts Jean Stanton (J&J), John Tomtishen (Novartis), Dr. Sadik Kassim (Mustang Bio), and Dr. Diane Wotta (Bio-Techne) as they discuss: what GMP really means in the context of raw materials and ancillary reagents; the quality of raw materials required along the commercialization pathway; when to start using GMP materials; and the current regulatory landscape.

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.